New app aims to objectively measure ADHD treatment effects

NCT ID NCT07217977

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Qbtech AB Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 27 times

Summary

This study looks at whether a mobile tool called QbMobile can accurately measure changes in ADHD symptoms after people start treatment. About 175 participants aged 6 to 60 with ADHD or ADD who are not currently on medication will take the test before and after starting treatment. The goal is to see if QbMobile provides a clearer, more objective way to track how well treatment is working.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY (ADHD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Bokhari Medical Consortium

Largo, Florida, 33770, United States
CCM Clinical Research Group

Miami, Florida, 33133, United States
Focus-MD

Mobile, Alabama, 36607, United States
Godwin Psychiatry

Goldsboro, North Carolina, 27534, United States
MindWell Urgent Care

Dallas, Texas, 75247, United States
Nona Pediatric Center

Orlando, Florida, 32829, United States
Prodigy Psychiatric Group

San Jose, California, 95138, United States

Conditions

Explore the condition pages connected to this study.

ATTENTION DEFICIT DISORDER (ADD) ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY (ADHD)